Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial

By sjmartinez • August 31, 2023

Chew KW, Moser C, Yeh E, Wohl DA, Daar ES, Ritz J, Javan AC, Eron JJ, Currier JS, Smith DM, Hughes MD; ACTIV-2/A5401 Study Team. Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial. J Infect Dis. 2023 Aug 31;228(Supplement_2):S83-S91. doi: 10.1093/infdis/jiad300. PMID: 37650237; PMCID: PMC10469584.

Tags: ACTIV-2, covid-19, Harbor UCLA, Infectious Diseases, internal validity, patient-reported outcomes, Publications, symptom diary, time to symptom resolution

Development of a Primary Care Cardio-Kidney Risk Navigator for Clinical Decision Support

Gluckman TJ, Birkeland K, Bhatt A, Budoff MJ, Danna SC, Desai NR, Norfolk E, Elbedewe A, Kiernan G, Pachpor R, Hirsch J. Development of a[...]

Predictive Value of Coronary Artery Calcium Score From Nongated Chest CT Scans Compared With Gated Scans and Incidence of Cardiovascular Events

Verghese D, Trujillo R, Abraham D, McClelland RL, Kinninger A, Manubolu S, Aldana J, Cubeddu RJ, Drachman D, Inglessis-Azuaje I, Wang DD, Fahed A, Brumback[...]

Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals

Abuknesha NR, O'Keefe JH, Qian F, Tintle NL, Lin Y, Sun Y, Qian HZ, Aisen PS, Albert CM, Aronson WJ, Asbeutah AAA, Bischoff-Ferrari HA, Budoff[...]